Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate injection for postoperative analgesia in pediatric laparoscopic surgery
ChiCTR2600135267Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine in postoperative pain (4 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Pharmacokinetic parameters after administration of oliceridine and Analgesic efficacy of oliceridine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600135267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135267.